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INTRODUCTION 
  Diabetes mellitus is a disorder characterized by uncontrolled sugar levels in the blood and 
its various manifestations to the human body. Diabetic foot and diabetic foot ulcers occurs as a 
complication of its sequelae. The different types include Type 1 and Type 2 diabetes mellitus 
based on insulin deficiency and resistance. 
The pathophysiology of diabetic foot ulcers is due tovasculopathies, neuropathy, wound 
infections and other factors like glycaemic control, hyperlipidemia etc. Based on the 
environmental status and the nature of the wound, a diabetic foot ulcer can heal. Deterrence to 
healing is brought about by persistent local insult or infection or poor vascularity. 
Due to increase in the incidence of diabetic ulcers, the management of diabetic ulcers 
have to be meticulous and due to poor care/ persistent local insult, the ulcer might lead to 
amputations of toes, foot or limb, which indirectly increases the morbidity in the individual 
affected and also decreases the quality of life.  
Various micro-organisms have been attributed as a deterrant to wound healing in 
diabetics. To cite a few would include Staphylococcus aureus, Escheria coli, Klebsiella 
pneumoniae, Proteus sp., Acinetobacter sp. and one of the most aggressive nosocomial pathogen 
Pseudomonas aeruginosa.  
Pseudomonas aeruginosa, a gram negative microbe, flagellate, has been a local deterrant 
to wound healing by its various properties of biofilm formation, increased virulence and multi 
drug resistance by various methods. Unfortunately, due to its resistance to first generation 
spectrum of antibiotics, and its gradual increase in resistance to higher spectrum of antibiotics 
(third generation cephalosporins, aminoglycosides), the need for alternative methodologies arise. 
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It has been shown that the local pH(alkaline) is essential for the ideal growth of the 
organism. Acetic acid being a weak acid has been used as a time old ingredient which helps in 
local control of the microbe by its various attributes, one of those including reducing the wound 
pH to acidic. 
This study will compare the efficacy of acetic acid based dressings and conventional 
dressings on Pseudomonas aeruginosa infected diabetic ulcers. 
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AIM AND OBJECTIVES 
AIM: 
To analyze the effect of 3% acetic acid dressings in eradication of Pseudomonas 
aeruginosa in comparison with conventional saline dressings in diabetic foot ulcers. 
OBJECTIVE 
 To study the effect of 3% acetic acid dressings on Pseudomonas aeruginosa infected 
diabetic foot ulcers 
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REVIEW OF LITERATURE 
Diabetic foot ulcer is one of the most debilitating complications of diabetes mellitus. It 
increases the morbidity and decreases the quality of life in almost all patients, with dreaded 
consequences such as gangrene and amputations. Early detection is important in order to avoid 
dreaded complications such as superceding infections and amputations.  
In the middle ages, diabetes was thought to be a rare disease and aggressive surgical 
management was the priority mostly leading to amputations. Arataeus was the first to describe 
diabetes and its symptoms. Diabetic symptoms were further described in detail by Matthew 
Dobson and William Cullen. Calvi recognized the association of diabetes with gangrene. With 
the discovery of insulin by Frederick Banting, the management of diabetics improved 
significantly. It is currently considered a global epidemic. 
Diabetes mellitus has been classified as type 1 and type 2 diabetes. The severity is based 
on age at presentation, weight of the patient and presence or absence of ketoacidosis at 
presentation. A proper diagnosis is done with the help of long term follow up. Type 1 is based on 
insulin deficiency and may be autoimmune or post pancreatectomy status. Type 2 is based on 
insulin resistance. These patients usually develop insulin deficiency at a later period of time.  
Complications of diabetes mellitus can be classified as acute and chronic complications. 
Acute includes diabetic ketoacidosis, hypoglycemia and diabetic coma, which is managed in an 
ICU setting. Chronic complications include microvascular and macrovascular changes. 
November 14 is considered as “world diabetes day”. Amongst the various complications 
of diabetes, foot complications such as ulcers, neuropathies, gangrene etc have the greatest 
morbidity. 
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EPIDEMIOLOGY: 
Foster et al discovered in 1997 that nearly 30 percent of patients with diabetes mellitus 
have increased risk of developing foot ulcers. 15% of diabetics developing foot ulcers, 
accounting for 30% of the hospital admissions with the hospital stay of those patients being 60% 
longer than the rest of the patients. These high risk patients had an increased risk of 
amputations
(2)
. Diabetic foot ulcers account for nearly more than half of the amputations 
performed due to non traumatic causes. Diabetes is responsible for high mortalities with very 
high morbidities such as accounting for both lower limbs amputations in rare cases
(2)
. 
As of 2025, India is predicted to have more than 57 million people suffering from 
diabetes mellitus
 (2)
. 
INCIDENCE
(2)
: 
In the study conducted by Foster et al on diabetic patients, the incidence he noted was, 
Foot ulcers    – 1-4 % 
Toe amputations   –  2-6% 
Below knee amputations  –  1.6%. 
Prevalence of diabetic foot  –  5.3 – 10.5%. 
The overall healing period of the diabetic ulcer was estimated to be 3 months with 
persistence of a small ulcer for more than a year
(4)
. It was seen that the cost of living and quality 
of life were attributing to increased morbidity towards the patient which was proportional to the  
severity of the wound. 
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PATHOPHYSIOLOGY: 
Infection, ischaemia, neuropathy and persistent hyperglycaemia are the important 
pathogenic factors  
Diabetic vasculopathies include both microvasculopathic and macrovasculopathic 
changes. Large vessels affected have atherosclerotic changes and are pronounced in diabetics. 
Diabetics have a predeliction towards tibioperoneal vessels involvement
(5)
.the following table 
shows microvascular and macrovascular changes. 
MICROVASCULAR CHANGES 
DIABETIC NEPHROPATHY Renal damage occurs due to long standing 
diabetes mellitus. Most patients, if uncontrolled 
may lead to dialysis in long term. 
DIABETIC NEUROPATHY Decreased sensation of the extremeties is the 
earlier sign starting in foot due to 
microvasculopathy of vasa nervosa. It can lead to 
other complications such as Autonomic 
neuropathy 
DIABETIC RETINOPATHY Macular edema and neovascularization occurs 
which causes blindness 
DIABETIC ENCEPHALOPATHY Increase in decline of cognitive status leading to 
dementia 
DIABETIC CARDIOMYOPATHY Cardiac muscle is damaged and leads to impaired 
cardiac filling and leading to heart failure. 
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MACROVASCULAR CHANGES 
CORONARY ARTERY DISEASE Due to atherosclerosis, major coronary 
vessels get blocked leading to poor cardiac 
function due to muscle death. 
PERIPHERAL VASCULAR DISEASE Atherosclerosis leading to vasculopathy and 
diabetic foot. 
STROKE Due to block in carotids etc, leading to 
transient ischaemic attack 
DIABETIC FOOT It’s a complication that occurs due to sensory 
neuropathy and vascular damage. This leads 
to skin ulcers and infection. In further 
complications may lead to amputations. 
 
Neuropathic changes are usually seen in view of persistent hyperglycaemia. One should 
note the fact that neuropathic foot has a higher morbidity towards the patient since trivial trauma, 
leading to abcess/ ulceration/ gangrene gets unnoticed most of the time. And patients usually 
present when full blown complications such as cellulitis/ necrotizing fasciitis/ systemic sepsis 
present
(6)
.  
Wound infection deters the healing process of the diabetic ulcer and leads to amputations. 
It was seen wound infections had increased the risk of amputations by 90 times to that of a non-
infected wound
(8)
. 
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Other risk factors include hyperlipidemia, hypertension, smoking, obesity, genetic factors 
and hypercoagulability. Duration and severity of the hyperglycemia determine the extent of 
complications in the affected individual
(7)
. 
DIABETIC FOOT: 
Due to microvascular changes and neuropathic changes in the foot, the architecture of the 
foot is altered and is prone for trivial injuries. Hence adequate foot care has to be given to avoid 
injuries. Vasculopathies involved are usually multi segmental occlusions with predominance of 
tibial artery, peroneal vessels and small vessels and arterioles. If injuries predisposes to diabetic 
foot ulcers, then management involved should involve local wound hygiene and antibiotics as 
necessitated for wound infection control. Adequate care involves diabetic slippers based on 
podiatric scan and avoidance of callous formation and trivial trauma 
  
9 
PATHOGENESIS OF DIABETIC FOOT LESIONS 
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PATHOGENESIS OF DIABETIC FOOT ULCER 
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DIABETIC FOOT ULCERS: 
Diabetic foot ulcers are a complication of diabetes mellitus which results because of 
microvascular changes and neuropathic changes. It is a medical emergency because of risk of 
deep infection and risk of osteomyelitis. It occurs because of lack of injury awareness/ minor 
trauma/ poorly fitting footwear. Due to its deeper involvement in late stages, patients are at risk 
for amputations.  
Management is a multidisciplinary principle which involves wound care, avoidance of 
weight bearing and removal of offending footwear, and aggressive management of infection. 
And follow up with regular clinical foot assessment, daily individual foot inspection and regular 
and prompt callous debridements and cessation of smoking. 
MICROORGANISMS IN DIABETIC ULCERS: 
 It has been seen that the following microbial organisms are more common in diabetic 
foot ulcer isolates; S. aureus, E. coli, Pseudomonas, Klebsiella, Citrobacter sp., Proteus sp. With 
an overall predominance of Pseudomonas and Staphyloccus aureus. Biofilm production was seen 
in almost all organisms associated causing increased virulence and delayed wound healing
(8)
. 
Infection with micro-organisms usually causes an increase in the virulence factors and 
taxis of neutrophils towards organisms. In Pseudomonas aeruginosa infected ulcers, the organism 
produces a biofilm which, during taxis of neutrophils releases a series of toxic components. 
These toxic substances deter phagocytosis and causes oxidative stress which delays the 
physiological process of wound healing
(7)
. It is also seen that in chronic wounds, Pseudomonas 
aeruginosa infected wounds having a biofilm will deter the wound healing by increasing the 
inflammatory response.  
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As detailed later, the presence of persistent hyperglycemia triggers increased virulence of 
the organism in the wound and deters wound healing. 
CLASSIFICATION: 
Based on the characteristics of the diabetic wound, the following classifications are available 
to categorize based on the degree of involvement. 
1) Meggitt – Wagner Classification:(9) 
0 – Fully epithelialized ulcer 
1 – Superficial ulcer involving the dermal layer 
2 – Beyond the subcutaneous layer. Exposure of tendon or bone. 
3 – Ulcers involving deeper planes with osteomyelitis or with abcess. 
4 – Gangrene localized. 
5 – Extensive gangrene 
 
2) University of Texas Classification: 
1 – Healed wound 
2 – Superficial wound not involving tendon, capsule or bone 
3 – Wound penetrating to tendon or capsule 
4 – Wound penetrating to bone or joint. 
A – No infection/ ischemia 
B – Infection present 
C – Ischemia present 
D – Both infection and ischemia present. 
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3) Edmunds and Foster classification: 
         They classified diabetic wounds as neuropathic ulcers/ neuroischemic ulcers based 
on ankle brachial index measurement. 
 
4) Broadsky: 
A – no ischemia 
B – ischemia without gangrene 
C – limited gangrene 
D – extensive gangrene 
 
5) Macfarlane and Jeffcoate: (10) 
                They classified based on the size of the ulcer, presence of sepsis, neuropathy 
and arteriopathic changes. 
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Classification of wound infection based on clinical signs: 
 
 
MANAGEMENT OF DIABETIC WOUNDS: 
Various management methodologies have been implemented in treating diabetic wounds. 
1) Debridement 
2) Dressings  
3) Infection control 
4) Amputation/ correcting vasculopathies 
5) Off loading. 
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Debridement: 
Removal of unhealthy devitalized or necrotic tissue remains the mainstay of management 
of diabetic wounds, following which maintaining a clean environment and assessment of 
vascularity of the wound is essential. 
Debridement can involve surgical means (removal by dissection), dressings as 
necessitated, use of adjuncts such as collagenase/ tissue recombinant factor etc, followed by 
development of granulation tissue and application of split skin grafts/ use of muscle flaps/ skin 
flaps. 
Dressings: 
Variety of dressings are available. Few are mentioned below. 
(11)
 
1) Wet to dry dressings: 
It helps in wound bed preparation. It is one of the cheapest dressing methodologies and is 
classified under mechanical debridement. It is usually done once or twice a day as 
necessitated by the wounds. 
 
2) Antibacterial dressings: 
Topical antibiotics have its action for 12 hours and are less toxic. Examples include, 
metronidazole, silver dressings, neomycin, bacitracin, mupirocin etc. It should not be 
used on granulating wounds and healing wounds since it is cytotoxic to fibroblasts and 
keratinocytes. 
 
 
 
16 
3) Tulle dressings: 
They are gauze dressings immersed in paraffin, it is used in clean wounds and over skin 
grafts. It helps avoid trauma to healing wounds and provides a moist environment which 
helps in epithelial cell proliferation and migration. 
 
4) Polyurethane films: 
They are covered with a water proof coating which helps in diffusion of gases and water 
vapor and maintains a moist environment.  
 
5) Hydrogel dressings: 
They provide fluid to necrotic and slough wounds which helps in autolysis. This is best 
used in dry wounds with necrotic eschar. 
 
6) Hydrocolloid dressings: 
They are a combination of polymers like gelatin, pectin and cellulose and forms a 
waterproof dressing. They help in autolysis of dry necrotic wounds up to 50% better than 
wet to dry wounds. They also retain growth factors which helps in granulation and 
epithelialization.  
 
7) Alginate dressings: 
They are used in exudative dressings. It helps by absorbing 15-20 times their own weight 
in water and can be used in cavity wounds/ granulating wounds. 
 
8) Enzymes: 
Collagenase, papain containing ointments, fibrinolysin helps in degradation of slough and 
healing.  
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Infection control: 
Infection control in an infected diabetic wound is achieved by local antibiotic dressings 
or oral / parenteral antibiotics as necessitated. 
Off loading cast: 
Due to diabetic neuropathy, patients have altered pressure points for which appropriated 
slippers are advised. In diabetic foot ulcers, diabetic neuropathy can cause delayed wound 
healing due to pressure effect on the wound, which is managed best by using offloading contact 
cast dressings. This type of dressing will release the pressure points and help in better wound 
healing.  
Amputations: 
In case of extensive gangrene and poor vascularity, amputation of the involved segment is 
considered following which daily dressings and appropriate antibiotics are administered. Once 
wound healing is achieved, the raw area is approximated by suturing or split skin grafts. 
Pseudomonas aeruginosa:
 
Pseudomonas aeruginosa is one of the leading nosocomial pathogens worldwide. It is a gram 
negative microbe
(20)
. This micro-organism has natural resistance to most structurally unrelated 
antimicrobials available as studied by Mesaros et al. in 2007, attributing to the low permeability 
of its outer membrane (1/100 to that of Escheria coli, (Livermore, 1984)).  
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Pseudomonas aeruginosa is a Gram-negative rod measuring 0.5 to 0.8 μm by 1.5 to 3.0 μm. 
Almost all strains are motile by means of single polar flagellum. Some strains have two or three 
flagella. The flagella yield heat-labile antigens. The significance of antibody directed against 
these antigens, is unknown. Clinical isolates have pili, which are anti phagocytic and  aids in 
bacterial attachment, thereby promoting colonization. 
 
Pseudomonas species normally inhabits soil, water, and vegetation. It can be isolated from the 
skin, throat, and stool of healthy persons. They often colonize hospital food, sinks, taps and 
respiratory equipment. Spread is from patient to patient via contact with fomites or by ingestion 
of contaminated food and water. 
 
Diagnosis of P aeruginosa depends on its isolation combined with laboratory identification. It 
grows well on most laboratory media and is commonly isolated on blood agar plates or eosin-
methylthionine blue agar. It is identified on the basis of Gram morphology, inability to ferment 
lactose, a positive oxidase reaction, its fruity odour, and its ability to grow at 42° C. 
Fluorescence under ultraviolet radiation helps in early identification of P aeruginosa colonies 
and also is useful in suggesting its presence in wounds such as in diabetic wounds. Other 
pseudomonas are identified by specific laboratory tests
(24)
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MICROSCOPIC IMAGE OF P. AERUGINOSA 
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IMAGE SHOWING GROWTH OF P. AERUGINOSA IN BLOOD AGAR 
 
 
 
 
 
 
21 
IMAGE SHOWING THE STRUCTURE OF P. AERUGINOSA 
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THE GREEN PIGMENT PYOVERDIN AND BLUE PIGMENT PYOCYANIN ARE 
PRODUCED BY PSEUDOMONAS AERUGINOSA 
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Antibiotics in Pseudomonas:  
Pseudomonas aeruginosa is a notoriously difficult organism to control with antibiotics or 
disinfectants because of its varied resistance mechanisms. Its general resistance is due to a 
combination of factors. It is intrinsically resistant to many antimicrobial agents due to its low 
permeability of its cell wall. It has the genetic capacity to express a wide range of resistance 
mechanisms. It can become resistant through mutation, which regulate resistance genes. It can 
acquire additional resistance genes from other structures via plasmids, transposons and 
bacteriophages.  
Penetration of antibiotics through the cell envelope of P. aeruginosa: 
 All the major classes of antibiotics used to treat P.aeruginosa infections have to cross the 
cell wall to reach their targets. The aminoglycoside group of antibiotics (gentamicin, tobramycin, 
amikacin) inhibit protein synthesis by binding to the 30S subunit of the ribosome. 
Floroquinolones (ciprofloxacin) bind to the A subunit of DNA gyrase, which maintains the 
ordered structure of the chromosome 22 inside the cells. The beta-lactam antibiotics (e.g. 
piperacillin, ceftazidime, imipenem, meropenem and aztreonam) inhibit the peptidoglycan-
assembling transpeptidases located on the outer face of the cytoplasmic membrane. Finally the 
polymyxins (colomycin, colistin) bind to phospholipids in the cytoplasmic membrane, destroying 
its barrier function. The innate resistance of P. aeruginosa to all classes of antibiotics has 
generally been attributed to the decreased permeability of its cell wall. Failure of antibiotics to 
accumulate within the organism is due to a combination of restricted permeability of the outer 
membrane and the efficient removal of antibiotic molecules that do penetrate by the action of 
efflux pumps. 
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Alginate as a barrier:  
  A characteristic feature of P. aeruginosa strains in cystic fibrosis is the production of a 
loosely associated layer of the anionic polysaccharide, alginate, which surrounds the cells and 
binds them together in aggregates. It has been shown that alginate can bind cationic antibiotics 
such as the aminoglycosides and restrict their diffusion
(25).
 The effect on the overall sensitivity of 
mucoid P. aeruginosa is probably minimal. However, some mucoid isolates are fully sensitive to 
aminoglycosides
(26).
 
The outer membrane as a barrier: 
 The outer membrane of P. aeruginosa presents a significant barrier to the penetration of 
antibiotics, thereby restricting the rate of penetration of small hydrophilic molecules.  
The microbe also expresses various efflux pumps with wide substrate specificity 
(Livermore, 2001) and the presence of cephalosporinase (Nordmann and Guibert, 1998).  
   The mechanism of resistance in Pseudomonas aeruginosa can be attributed to the following 
mechanisms. 
1. Impermeability 
2. Active efflux 
3. Target modification 
4. Non-enzymatic methods. 
Impermeability: 
This kind of resistance is attributed to the diminished outer membrane permeability of the 
microbe. (Bryan et al. 1976) 
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Active Efflux: 
This type of mechanism is rare and is due to the expression of MexXY proteins with 
OprM (Masuda et al. 2000a). other proteins involved can be cited along as OpmB, OpmG, OpmI 
(Jo et al., 2003). The multidrug efflux systems are composed of three protein components, viz 
energy-dependent pump located in the cytoplasmic membrane, an outer membrane porin and a 
linker protein which couples the two membrane components together
(27).
 This arrangement forms 
an efficient extrusion system for toxic molecules present in the cytoplasm, the cytoplasmic 
membrane or the periplasm, i.e. the region between the outer and cytoplasmic membranes. Four 
different antibiotic efflux mechanisms have been described in P. aeruginosa: mexAB-oprM, 
mexXY-oprM, mexCD-oprJ and mexEF-oprN
(28)
. All classes of antibiotics except the 
polymyxins are susceptible to extrusion by one or more of the efflux systems. 
Target Modification: 
Methylation of 16S rRNA is a mode of resistance to aminoglycosides, exhibited by the 
organism (Doi and Arakava, 2007). This is brought about by the 16S rRNAmethylases which 
share its structural skeleton with that of aminoglycoside producing actinomycetes.  
The genes responsible are located in transposons and are transmitted by plasmids. This 
type of resistance was first noted in Japan, 2003 (Yokoyama et al., 2003). This hence provides 
resistance to aminoglycosides such as amikacin, tobramycin, gentamycin etc. 
Non enzymatic mechanisms: 
Four genes have been isolated in Pseudomonas aeruginosa which is known to cause 
gradual resistance in the organism to antibiotics. They are galU, nuoG, mexZ and rplY(El’Garch 
et al., 2007). The galU gene forms UDP-glucose pyrophosphorylase which converts glucose-1-
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phosphate to UDP-glucose, which is essential for the synthesis of a complete LPS outer core, 
which increases its resistance. The nuoG gene causes increased antibiotic efflux from the 
organism. The mexZ is responsible for antibiotic efflux to aminoglycosides and the rplY gene is 
responsible for increased growth of the organism
(30)
.  
A lot of multi drug resistant strains have come into picture, with the above resistance 
mechanisms. Thus this microbe proves to be a hindrance to manage in an infected diabetic foot 
ulcer in a clinical setting.  
Various strains of Pseudomonas aeruginosa with varied natural has been found to have 
resistance to the following antibiotics 
1. Beta lactams – penicillin G 
2. Aminopenicillins 
3. Antibiotics combined with beta lactam inhibitors 
4. First, second and third generation cephalosporins. 
5. Aminoglycosides. 
The microbe also acquires additional resistance mechanisms via metallo-beta-lactamase 
(MBL)-mediated resistancewhich shows resistance to carbapenems
(31)
. 
Role of Biofilms: 
Biofilms provide protection from antimicrobial agents by forming a physical barrier and 
play an important role in infection control
(14)(15)
. Gram negative organism Pseudomonas 
aeruginosa is a microbe that is known for its biofilm secreting nature and due to which is 
resistant to local inflammatory mediators which are usually helpful in locoregional control. It 
also has a high resistance to conventional antibiotics such as beta lactams.  
27 
ACETIC ACID: 
Acetic acid is also known as formic acid, a colourless liquid. Its chemical formulation is  
CH3COOH. It has a sour taste and is pungent. It is classified under weak acids. Concentrated 
acetic acid can corrode skin. 
ACETIC ACID 3D CONFIGURATION: 
 
Key: Black – carbon; White – Hydrogen; Red – Oxygen. 
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The hydrogen part of carboxyl group (−COOH in acetic acid can separate from the 
molecule by ionization. This results in its acidic character. It has multiple uses. It is used as a 
part of cervical cancer screening
(29)
. It is used as an antimicrobial agent for locoregional control 
in skin infections.  
Role of Acetic acid: (CH3COOH) 
(21)
 
Acetic acid is considered an antimicrobial agent and has low toxicity
(16)(17)
. It has the 
following actions
(18)
. 
a) Its acidic nature 
b) Neutralize electrochemical potential 
c) Lowering pH of the wound on application 
Thomas bjornsholt et al. have evaluated the efficacy of acetic acid in various 
concentrations and its role in lowering the pH of the wound. It has been seen that the unaltered 
acetic acid molecule is responsible for lowering the pH and its effect in removing the biofilm 
also helps in reducing the infective rate of the organism 
(32)
. 
Kapil et al. (2017) have assessed the efficacy of 1% acetic acid in various concentrations 
towards various microbes and have seen that the local pH of the wound was altered and acetic 
acid is efficient in eradication of multiple organism and fungi 
(22)
.  
The effect of low pH on wound healing was also studied by Basavaraj et al. (2015). It 
was seen that the acidic environment also promotes epithelization and angiogenesis. In a 
histopathological study on chronic wound infections, use of citric acid was shown to enhance 
epithelization and found to actuate the wound healing process by boosting fibroblastic growth 
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and neovascularization, which increases microcirculation of wounds that enables the formation 
of healthy granulation tissue, thereby leading to faster healing of wounds.
(23)
 
Acquirement of carbapenemases by Pseudomonas aeruginosa and other strains have led 
to a difficulty in management of pseudomonas aeruginosa infected diabetic wounds. It has also 
led to increased morbidity of the affected individual due to the need for prolonged hospital stay 
and need for higher antibiotics for its eradication. 
 
ACETIC ACID DRESSINGS: 
Chronic wounds do not progress to the proliferative phase of wound healing and undergo 
a detention in the inflammatory phase of healing because of which there is a continuous influx of 
neutrophils into the wound area, with the release of free radicals, cytolytic enzymes and 
inflammatory mediators that cause damage to the invading pathogens as well as to the host 
tissue
(13)
. 
Presence of an infectious component prevents wound healing by various factors. When 
the contamination increases to a point of critical colonisation or infection, then the infection or 
the bioburden in the wound becomes a major contributing factor that impedes wound healing
(12)
. 
Acetic acid, as seen from above, is bactericidal against many organisms, especially towards 
Pseudomonas aeruginosa. It can be used in concentrations from 0.5 – 5% as topical applicant in 
wounds infected with Pseudomonas aeruginosa and has been seen to be effective in its 
eradication. It does not cause removal of epithelialization from 8
th
 day and has no effect in 
tensile strength of the wound
(19)
. 
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Use of acetic acid in the concentrations mentioned above can provide a viable alternative 
to conventional antibiotics in elimination of the organism and thereby help in wound healing, 
decrease in morbidity and attaining locoregional control. 
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MATERIALS AND METHODS 
This study is done to compare the efficacy of 3% acetic acid in the eradication of 
Pseudomonas aeruginosa in P. aeruginosa infected diabetic ulcers in comparison to traditional 
saline dressings.  
INCLUSION CRITERIA: 
 Patients with diabetic foot ulcers with culture proven Pseudomonas aeruginosa infection. 
EXCLUSION CRITERIA: 
 Ischaemic ulcer/ venous ulcer/ ulcer with vasculitis 
 Osteomyelitic changes 
 Ulcers with bones/ tendons exposed 
 Immunocompromised patients 
 Non consenting patients 
This study was conducted in patients with Pseudomonas aeruginosa infected diabetic 
ulcers in the department of General Surgery, General medicine, Cardiology, Nephrology and 
Neurology in PSG Institute of Medical Sciences and Research. The period of study was between 
November 2016 to November2018. It is an open labelled prospective randomized control trial. 
80 individuals with P. aeruginosa infected diabetic ulcers participated in this study. All 
the patients had diabetic foot ulcers and satisfied both inclusion and exclusion criteria for this 
study. 
Written informed consents were obtained from the patients and detailed clinical history of 
the patient and other data were collected from the patients who participated in this study. 
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The following details were collected. Name, age, sex, diabetic status, onset and duration 
of ulcer and culture sensitivity reports on day 0 and day 10. Each patient was followed up for 10 
days and their culture reports were analyzed. 
The patients were divided into two groups based on simple randomization into test and 
control groups. 
Test group :  40 
Control group :  40 
Acetic acid preparation 
 
Acetic acid preparation: 
3% acetic acid was prepared by titrating 100% Glacial acetic acid with distilled water. 
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DIABETIC FOOT ULCER OF A PATIENT WITH PSEUDOMONAS AERUGINOSA ON 
ACETIC ACID DRESSING DAY 10 
 
Dressing procedure: 
Test group :  (3% AA) 
This group received 3% acetic acid dressing. 3% acetic acid was taken in a sterile 
container and sterile gauze was soaked in it. After thorough cleansing of the wound with saline, 
3% acetic acid is placed over the wound and gamgee pad was placed over it following which the 
wound was closed in roller bandage. This was done twice daily for 10 days and culture 
sensitivity was sent on 10
th
 day. 
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Control group  :  (SD) 
This group received traditional saline dressings. Under aseptic precautions, patient’s 
wound was thoroughly cleansed with saline and sterile gauze was placed over the raw area 
following which gamgee pad was placed and wound dressed. 
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DIABETIC FOOT ULCER OF A PATIENT WITH PSEUDOMONAS AERUGINOSA ON 
CONVENTIONAL SALINE DRESSING DAY 10 
This was done twice daily for 10 days and culture sensitivity was sent on 10
th
 day. 
The data was collected and tabulated in an EXCEL spreadsheet. The test variables and 
the control variables were tabulated and compared using Chi square test. Percentages, mean 
values and statistical significance values were derived. A type I error of 0.05 was taken into 
consideration in all analysis.  
The efficacy of 3% Acetic acid in eradication of Pseudomonas aeruginosa infected 
diabetic ulcers was assessed by reviewing the culture reports on day 10 amongst all patients in 
both groups using the above statistical tools. p<0.01 was seen and was considered to be 
statistically significant in the above study, thereby demonstrating a better outcome in eradication 
of P. aeruginosa in P. aeruginosa infected diabetic ulcers using 3% acetic acid. 
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DAY 0 – ACETIC ACID DRESSING 
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DAY 10 – ACETIC ACID DRESSING 
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DAY 0 – SALINE DRESSING 
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DAY 10 – SALINE DRESSING 
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DAY 10 SALINE DRESSING 
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DAY 10 ACETIC ACID DRESSING 
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DAY 10 SALINE DRESSING 
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DAY 10 ACETIC ACID DRESSING 
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DAY 10 ACETIC ACID DRESSING 
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DAY 10 SALINE  DRESSING 
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DAY 10 ACETIC ACID DRESSING 
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DAY 10 ACETIC ACID DRESSING 
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DAY 10 SALINE DRESSING 
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DAY 10 SALINE DRESSING 
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DAY 10 SALINE DRESSINGS 
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METHODOLOGY 
 
AIM 
 
To analyze the effect of 3% acetic acid dressings in eradication of 
Pseudomonas aeruginosa in comparison to conventional saline 
dressings in Pseudomonas aeruginosa infected diabetic ulcers. 
 
STUDY DESIGN 
 
Open labelled prospective randomized control trial 
 
STUDY POPULATION 
 
In patients and out patients from departments of General Surgery, 
General Medicine, Cardiology, Nephrology and Neurology from 
November 2016  to November 2018, were included in this study 
 
SAMPLE SIZE 
 
80 
 
INCLUSION CRITERIA 
 
Patients with diabetic foot ulcers with culture proven Pseudomonas 
aeruginosa positive status 
 
EXCLUSION CRITERIA 
 
 Ischaemic ulcer/ venous ulcer/ ulcer with vasculitis 
 Osteomyelitic changes 
 Ulcers with bones/ tendons exposed 
 Immunocompromised patients 
 Non consenting patients 
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DURATION OF STUDY 
 
1 year 
 
STUDY PERIOD 
 
November 2016 to November 2018 
 
STUDY PROFORMA: 
Effect of 3% acetic acid dressings in Pseudomonas aeruginosa positive diabetic ulcers 
1) IDENTIFICATION NO. 
2) AGE 
3) SEX 
4) IP NO./ OP NO. 
5) DIABETIC ULCER 
a) ONSET – TRAUMATIC/SPONTANEOUS/OTHERS 
b) DURATION 
6) TYPE OF DRESSING –  
3% AA/ SD 
7) CULTURE STATUS DAY 0 –  
8) CULTURE STATUS DAY 10 –  
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RESULTS AND STATISTICAL ANALYSIS 
Amongst individuals, both inpatients and out patients of the included sample size in this 
study, from the departments of general Surgery, General Medicine, Neurology, Nephrology and 
Cardiology were included in this study. Consent was obtained. 
Table 1: 
CULTURE STATISTICS – TEST GROUP 
Culture results after dressings 
Test Group 
n % 
Growth Present 5 12.50% 
Growth Absent 35 87.50% 
Total 40 100.00% 
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12.5%
87.5%
CULTURE STATISTICS – TEST GROUP
Positive
Negative
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Table 2: 
CULTURE STATISTICS – CONTROL GROUP 
Culture results after dressings 
Control Group 
n % 
Growth present 15 37.50% 
Growth absent 25 62.50% 
Total 40 100.00% 
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37.5%
62.5%
CULTURE STATISTICS – CONTROL GROUP
Positive
Negative
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Table 3: 
CHI-SQUARE ANALYSIS 
Culture prior 
dressings 
Test Control Total 
n % n % n % 
Growth present 40 100.00% 40 100.00% 80 100.00% 
Growth absent 0 0.00% 0 0.00% 0 0.00% 
Total 40 100.00% 40 100.00% 80 100.00% 
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t
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Group-wise Culture prior dressings
Test
Control
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Table 4: 
CHI-SQUARE ANALYSIS – TEST AND CONTROL GROUP 
Culture results after 
dressings 
Test Control Total 
n % n % n % 
Growth present 5 12.50% 15 37.50% 20 25.00% 
Growth absent 35 87.50% 25 62.50% 60 75.00% 
Total 40 100.00% 40 100.00% 80 100.00% 
Chi-Square Test p-value = 0.009 
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TEST – ACETIC ACID DRESSINGS 
CONTROL – CONVENTIONAL SALINE DRESSINGS 
 
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
Positive Negative
12.5%
87.5%
37.5%
62.5%
END RESULT AFTER DRESSINGS
Test
Control
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Table 5: 
CHI-SQUARE ANALYSIS – GENDER VARIATION 
Sex 
Test Control Total 
n % n % n % 
Male 28 70.00% 26 65.00% 54 67.50% 
Female 12 30.00% 14 35.00% 26 32.50% 
Total 40 100.00% 40 100.00% 80 100.00% 
Chi-Square Test p-value = 0.406 
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Table 6: 
GENDER DISTRIBUTION – ACETIC ACID DRESSINGS GROUP 
Test - Group 
             Gender 
 
Age Group 
Male Female Total 
n % n % n % 
Below 31 yrs 0 0.00% 1 2.50% 1 2.50% 
31 - 40 yrs 2 5.00% 1 2.50% 3 7.50% 
41 - 50 yrs 4 10.00% 2 5.00% 6 15.00% 
51 - 60 yrs 9 22.50% 2 5.00% 11 27.50% 
61 - 70 yrs 6 15.00% 5 12.50% 11 27.50% 
71 - 80 yrs 7 17.50% 1 2.50% 8 20.00% 
Total 28 70.00% 12 30.00% 40 100.00% 
Chi-Square Test p-value = 0.355 
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GROUP
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Table 7: 
GENDER DISTRIBUTION – SALINE DRESSINGS GROUP 
Control-Group 
     Gender 
 
 Age Group 
Male Female Total 
n % n % n % 
Below 31 yrs 1 2.50% 1 2.50% 2 5.00% 
31 – 40 yrs 3 7.50% 1 2.50% 4 10.00% 
41 – 50 yrs 4 10.00% 3 7.50% 7 17.50% 
51 – 60 yrs 7 17.50% 1 2.50% 8 20.00% 
61 – 70 yrs 6 15.00% 6 15.00% 12 30.00% 
71 – 80 yrs 4 10.00% 2 5.00% 6 15.00% 
81 – 90 yrs 1 2.50% 0 0.00% 1 2.50% 
Total 26 65.00% 14 35.00% 40 100.00% 
Chi-Square Test p-value = 0.666 
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67 
Table 8: 
ACETIC ACID GROUP – GENDER VARIATION 
                Day 10 Culture 
       Sex 
Growth present Growth absent Total 
n % n % n % 
Male 5 12.50% 23 57.50% 28 70.00% 
Female 0 0.00% 12 30.00% 12 30.00% 
Total 5 12.50% 35 87.50% 40 100.00% 
Chi-Square Test p-value = 0.149 
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Table 9: 
CONVENTIONAL DRESSINGS GROUP – GENDER VARIATION 
             Day 10 culture 
    Sex 
Growth present Growth absent Total 
n % n % n % 
Male 11 27.50% 15 37.50% 26 65.00% 
Female 4 10.00% 10 25.00% 14 35.00% 
Total 15 37.50% 25 62.50% 40 100.00% 
Chi-Square Test p-value = 0.307 
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Table 10: 
ACETIC ACID DRESSIGNS GROUP – AGE DISTRIBUTION 
           Day 10 Culture 
 
Age Group 
Growth present Growth absent Total 
n % n % n % 
Below 31 yrs 0 0.00% 1 2.50% 1 2.50% 
31 - 40 yrs 1 2.50% 2 5.00% 3 7.50% 
41 - 50 yrs 1 2.50% 5 12.50% 6 15.00% 
51 - 60 yrs 1 2.50% 10 25.00% 11 27.50% 
61 - 70 yrs 1 2.50% 10 25.00% 11 27.50% 
71 - 80 yrs 1 2.50% 7 17.50% 8 20.00% 
Total 5 12.50% 35 87.50% 40 100.00% 
Chi-Square Test p-value = 0.894 
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Table 11: 
CONVENTIONAL DRESSIGNS GROUP – AGE DISTRIBUTION OF DAY 10 
CULTURE STATUS 
             Day 10 Culture 
 
Age Group 
Growth Present Growth Absent Total 
n % n % n % 
Below 31 yrs 2 5.00% 0 0.00% 2 5.00% 
31 - 40 yrs 2 5.00% 2 5.00% 4 10.00% 
41 - 50 yrs 2 5.00% 5 12.50% 7 17.50% 
51 - 60 yrs 1 2.50% 7 17.50% 8 20.00% 
61 - 70 yrs 4 10.00% 8 20.00% 12 30.00% 
71 - 80 yrs 4 10.00% 2 5.00% 6 15.00% 
81 - 90 yrs 0 0.00% 1 2.50% 1 2.50% 
Total 15 37.50% 25 62.50% 40 100.00% 
Chi-Square Test p-value = 0.183 
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Table 12: 
INDEPENDENT T-TEST ANALYSIS 
Age N Mean SD p-value 
Test 40 58.63 13.06 
0.596 
Control 40 56.95 15.05 
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DISCUSSION 
An open labelled prospective randomized control study was conducted to assess the 
efficacy of acetic acid dressing in eradication of Pseudomonas aeruginosa in Pseudomonas 
aeruginosa infected diabetic ulcers to those of traditional saline dressings for the same. 
It is well known that diabetic ulcers increase the morbidity of the affected individual and 
delayed wound healing in the presence of infected wounds. It should therefore be mandatory to 
prevent the development of diabetic foot ulcers at the earliest by identifying diabetic peripheral 
neuropathic changes. In case of a formed ulcer, in diabetic individuals, adequate care must be 
initiated to prevent the ulcer from causing irreparable damage. 
Care involved is multifactorial from the choice of dressings, frequency of dressings, 
glycaemic control, infection control to debridements. In patients with Pseudomonas aeruginosa 
infected diabetic foot ulcers, due to the prevalence of multiple strains with resistance to 
betalactams and carbapenems and the ability to produce biofilms, care administered gets difficult 
due to poor loco-regional control.  
Acetic acid provides a cheaper alternative in eliminating Pseudomonas aeruginosa in P. 
aeruginosa infected diabetic wounds by reducing the pH of the wound and its ability to denature 
proteins. Literatures reviewed on the use of acetic acid on elimination of Pseudomonas 
aeruginosa in diabetic ulcers and chronic ulcers have shown promising results. 
Thomas et al, have studied the effect of biofilm formation and antibiotic resistance by 
pseudomonas aeruginosa and its effect in delayed wound healing. It was seen that biofilms resist 
and or tolerate all antibiotics and promote pathogen growth.  
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Nagoba et al in 2008 studied the effect of 3-5% acetic acid’s topical application two to 
twelve times over the P. aeruginosa infected diabetic wound successfully eradicated the 
organism. Ryssel H et al in 2010 studied the effect of acetic acid matrix dressing in burn wounds 
and found them to be effective in eradication of the organism.  
In this study, we compared the eradication of Pseudomonas aeruginosa in infected 
diabetic ulcers by using 3% acetic acid to that of conventional saline dressings at the end of 10 
days. All patients received conventional antibiotics via oral and/or parenteral based on culture 
sensitivity. At the end of the study, both groups of 40 individuals each were compared. It was 
seen that there was complete eradication of Pseudomonas aeruginosa in 35 individuals in those 
treated with 3% acetic acid to that of 25 individuals in the control group (treated with traditional 
saline dressings).  
70% of the individuals were males in the test group to that of 65% in control group, with 
the maximum affected individuals in 51-70 age group. 87.5% of the individuals in the test group 
had complete eradication of the organism with acetic acid dressings and 62.5% of the individuals 
in the control group had complete eradication of the organism with traditional saline dressings. 
The percentage elimination of pseudomonas aeruginosa showed a statistical significance 
(p=0.009), with independent t analysis having (p-0.596) suggesting no bias. It was thus 
concluded that Acetic acid dressings help in maintaining locoregional control of Pseudomonas 
aeruginosa and eradication of the organism.  
It is also to be noted that acetic acid proves to be a considerable economic advantage due 
to its easy availability and better efficacy in eradicating the organism. The limitations of this 
study to note is its small sample size. 
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CONCLUSION 
 Acetic acid is easily available and is an economic alternative in providing loco regional 
control for multidrug resistant Pseudomonas infected diabetic foot ulcers 
 Acetic acid dressings, in 3% concentrations, help in complete eradication of P. aeruginosa in 
diabetic ulcers. 
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MASTER CHART 
S. No Reg No. Culture day 0 Culture day 10 age/sex S. No Reg No. Culture day 0 Culture day 10 age/sex 
1 I16035579 positive negative 40/F 1 I17002783 Positive Positive 62/M 
2 I16037886 positive negative 62/M 2 i17005481 Positive Positive 72/F 
3 i16039442 positive negative 67/F 3 I17011529 Positive Positive 80/M 
4 I16039778 positive negative 74/F 4 I17012887 Positive Positive 17/M 
5 i17003390 positive negative 60/M 5 I17019565 Positive Positive 63/M 
6 I17007786 positive negative 32/M 6 I17036716 Positive Positive 48/M 
7 I17007941 positive negative 68/M 7 I17045062 Positive Positive 71/M 
8 I17010037 positive negative 45/F 8 O17029237 Positive Positive 29/F 
9 I17028963 positive negative 76/M 9 O17066534 Positive Positive 70/F 
10 I17029101 positive negative 54/F 10 I17054425 Positive Positive 45/M 
11 I17036133 positive negative 73/M 11 I17016447 Positive Positive 32/M 
12 I17046689 positive negative 78/M 12 I17020404 Positive Positive 38/M 
13 O08035473 positive negative 62/F 13 I17017294 Positive Positive 67/M 
14 O14072019 positive negative 68/F 14 I16035290 Positive negative 56//M 
15 O15034068 positive negative 48/F 15 I17001568 Positive positive 57/M 
16 O16085405 positive negative 59/F 16 I17004178 Positive negative 70/F 
17 O16087387 positive negative 58/M 17 I17008809 Positive positive 76/F 
18 O17053789 positive negative 57/M 18 I17011075 Positive negative 81/M 
19 O17092203 positive negative 49/M 19 I17014646 Positive negative 52/F 
20 I17026746 positive negative 24/F 20 I17016796 Positive negative 65/F 
21 I17028088 positive negative 59/M 21 I17017409 Positive negative 48/M 
22 O12049867 positive negative 55/M 22 I17019343 Positive negative 48/M 
23 I17026791 positive negative 65/F 23 I17024559 Positive negative 61/F 
24 I17028963 positive negative 76/M 24 I17028473 Positive negative 31/M 
25 I17039680 positive negative 65/M 25 I17029622 Positive negative 55/M 
26 I17040962 positive negative 58/M 26 I17040672 Positive negative 49/F 
27 I17050406 positive negative 75/M 27 I17045989 Positive negative 45/F 
28 O08035473 positive negative 62/F 28 I17049268 Positive negative 42/F 
29 O17001956 positive positive 33/M 29 I17052380 Positive negative 73/M 
30 O16086318 positive positive 44/M 30 O07006558 Positive negative 70/F 
31 I16036285 positive negative 43/M 31 O09059011 Positive negative 63/M 
32 I17008425 positive negative 57/M 32 O10052667 Positive negative 68/M 
33 o17044087 positive negative 56/M 33 O12030522 Positive negative 66/M 
34 i16021564 positive negative 48/M 34 O13071286 Positive negative 57/m 
35 i16021569 positive negative 63/M 35 O13092026 Positive negative 54/M 
36 I17019565 positive negative 63/M 36 O14018087 Positive negative 58/M 
37 O17005495 Positive positive 75/M 37 O15080291 Positive negative 65/F 
38 O17077943 positive positive 65/M 38 O16078496 Positive negative 76/M 
39 I17010327 positive positive 53/M 39 O16084092 Positive negative 60/M 
40 I17023889 Positive negative 76/M 40 I17035972 Positive negative 38/F 
   
(5)/(35) 
    
(15)/(25) 
 
 
